Nuvilex, Inc. Readies Pancreatic Cancer Treatment For Expanded Phase II Clinical Trials
Links shared publicly online about this topic.
- 236total visits
Nuvilex, Inc. Readies Pancreatic Cancer Treatment For Expanded Phase II Clinical Trials
Nuvilex, Inc. (OTCQB: NVLX) announced today it is aggressively engaging the steps necessary to use its encapsulated cell technology for pancreatic cancer in expanded Phase II clinical trials in th
View full resource at medicalnewstoday.com
Tags: Pancreatic Disease, Cancer, Pancreatic Cancer, Clinical Trial
Most Recently Shared on June 7, 2011 at 4:06 pm By:
Nuvilex, Inc. Readies Pancreatic Cancer Treatment For Expanded Phase II Clinical Trials http://mnt.to/3WSw #pancreaticcancer
Advertisement
